...
首页> 外文期刊>Medical oncology >Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy.
【24h】

Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy.

机译:蒽环类化学疗法治疗的乳腺癌患者的内膜中层厚度,心肌灌注和动脉粥样硬化的实验室危险因素。

获取原文
获取原文并翻译 | 示例

摘要

An increased incidence of complications of atherosclerosis has been noted in cancer survivors. The aim of the present study was to evaluate, in patients with breast carcinoma, the effect of antracycline-based chemotherapy on carotid intima-media thickness (IMT), myocardial perfusion, assessed by single-photon emission tomography (SPECT) and laboratory parameters associated with the risk of atherosclerosis. Thirty-six patients with breast cancer were evaluated before and after anthracycline-based chemotherapy. Retinol, alpha-tocopherol, glycosylated hemoglobin and urinary neopterin were measured by high-performance liquid chromatography. Peripheral blood cell count, D-dimers, fibrinogen, antithrombin, glucose, magnesium, creatinine, uric acid, albumin, C-reactive protein, lipoprotein (a), cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, homocysteine, urinary albumin and N-acetyl-beta-D-glucosaminidase (NAG) were determined with routine methods. No significant differences were observed between patients and 16 controls. Compared to the measurement before the start of therapy, peripheral blood leukocyte and platelet count, hemoglobin, creatinine, HDL cholesterol, retinol, albumin, urinary albumin and NAG decreased, and total cholesterol, LDL cholesterol, triglycerides, neopterin and mean IMT increased significantly after the treatment. Of the 36 patients who had SPECT after treatment, perfusion defects were noted only in two cases, including the patient who had perfusion defects at baseline examination and a patient who did not have a baseline SPECT. In conclusion, a significant increase in carotid IMT, total cholesterol, LDL cholesterol, triglycerides and urinary neopterin and a decrease of peripheral blood leukocyte and platelet counts, hemoglobin, creatinine, HDL cholesterol, retinol, albumin and NAG were observed after the treatment.
机译:在癌症幸存者中已经注意到动脉粥样硬化并发症的发生率增加。本研究的目的是通过单光子发射断层扫描(SPECT)和相关的实验室参数评估乳腺癌患者中基于环霉素的化学疗法对颈动脉内膜中层厚度(IMT),心肌灌注的影响有动脉粥样硬化的风险。在基于蒽环类药物的化疗前后,对36例乳腺癌患者进行了评估。通过高效液相色谱法测定视黄醇,α-生育酚,糖基化血红蛋白和尿新蝶呤。外周血细胞计数,D-二聚体,纤维蛋白原,抗凝血酶,葡萄糖,镁,肌酐,尿酸,白蛋白,C反应蛋白,脂蛋白(a),胆固醇,高密度脂蛋白(HDL)胆固醇,低密度脂蛋白( LDL)胆固醇,甘油三酸酯,高半胱氨酸,尿白蛋白和N-乙酰基-β-D-氨基葡萄糖苷酶(NAG)用常规方法测定。患者和16名对照之间未观察到显着差异。与开始治疗前相比,外周血白细胞和血小板计数,血红蛋白,肌酐,HDL胆固醇,视黄醇,白蛋白,尿白蛋白和NAG降低,总胆固醇,LDL胆固醇,甘油三酸酯,新蝶呤和平均IMT显着增加。治疗。在治疗后有SPECT的36例患者中,仅在2例中发现了灌注缺陷,包括基线检查时有灌注缺陷的患者和没有基线SPECT的患者。总之,治疗后观察到颈动脉IMT,总胆固醇,LDL胆固醇,甘油三酸酯和尿新蝶呤显着增加,外周血白细胞和血小板计数,血红蛋白,肌酐,HDL胆固醇,视黄醇,白蛋白和NAG减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号